Guoliang Hu Selected Research

Floating-harbor syndrome

1/2024	Sodium butyrate alleviates free fatty acid-induced steatosis in primary chicken hepatocytes via the AMPK/PPARα pathway.
12/2023	Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens.
7/2021	Preparation of the peroxisome proliferator-activated receptor α polyclonal antibody: Its application in fatty liver hemorrhagic syndrome.
1/2021	Serum Metabolomic Profiling to Reveal Potential Biomarkers for the Diagnosis of Fatty Liver Hemorrhagic Syndrome in Laying Hens.
4/2020	Abnormal expression of liver autophagy and apoptosis-related mRNA in fatty liver haemorrhagic syndrome and improvement function of resveratrol in laying hens.
2/2020	The protective effects of resveratrol on antioxidant function and the mRNA expression of inflammatory cytokines in the ovaries of hens with fatty liver hemorrhagic syndrome.
12/2019	Insulin resistance and metabonomics analysis of fatty liver haemorrhagic syndrome in laying hens induced by a high-energy low-protein diet.
5/2019	Effects of fatty liver hemorrhagic syndrome on the AMP-activated protein kinase signaling pathway in laying hens.
11/2017	Improving effect of dietary soybean phospholipids supplement on hepatic and serum indexes relevant to fatty liver hemorrhagic syndrome in laying hens.
10/2017	Abnormal histopathology, fat percent and hepatic apolipoprotein A I and apolipoprotein B100 mRNA expression in fatty liver hemorrhagic syndrome and their improvement by soybean lecithin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guoliang Hu Research Topics

Disease

16	Inflammation (Inflammations) 01/2024 - 01/2016
12	Fatty Liver 01/2024 - 10/2017
11	Infections 11/2023 - 01/2015
10	Floating-harbor syndrome 01/2024 - 10/2017
6	Poisoning 01/2024 - 06/2020
6	Body Weight (Weight, Body) 01/2023 - 05/2017
5	Ascites 12/2023 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 09/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 07/2023 - 02/2021
3	Neoplasms (Cancer) 05/2023 - 12/2020
3	Dysbiosis 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 12/2023 - 01/2017
2	Ischemic Stroke 09/2022 - 12/2021
2	Hemorrhage 01/2022 - 07/2016
2	Hyperglycemia 01/2022 - 11/2004
2	Liver Diseases (Liver Disease) 04/2020 - 11/2017
2	Insulin Resistance 12/2019 - 11/2009
1	Rupture 03/2024
1	Cardiotoxicity 01/2024
1	Diabetes Complications 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Iron Overload 03/2023
1	Mastitis 01/2023
1	Diarrhea 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Neoplasm Metastasis (Metastasis) 07/2022
1	Pulmonary Hypertension 07/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2020
12	Messenger RNA (mRNA)IBA 01/2024 - 01/2015
6	AntioxidantsIBA 05/2023 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
5	LipidsIBA 01/2024 - 12/2019
4	CytokinesIBA 01/2022 - 01/2020
3	CopperIBA 07/2023 - 01/2021
3	DichlorvosIBA 01/2022 - 06/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2019
3	MercuryIBA 05/2021 - 01/2020
3	Amino Acids FDA Link 01/2021 - 11/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2014 - 09/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 03/2021
2	Butyric Acid (Butanoic Acid)IBA 01/2024 - 01/2024
2	chromium hexavalent ionIBA 01/2024 - 01/2022
2	Long Noncoding RNAIBA 12/2023 - 08/2016
2	baicalinIBA 11/2023 - 05/2023
2	FlavonoidsIBA 11/2023 - 12/2022
2	LipopolysaccharidesIBA 06/2023 - 12/2022
2	QuercetinIBA 06/2023 - 12/2022
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2023 - 05/2021
2	HMGB1 Protein (HMG1)IBA 12/2022 - 06/2022
2	Recombinant ProteinsIBA 07/2022 - 07/2021
2	InflammasomesIBA 06/2022 - 01/2022
2	NF-kappa B (NF-kB)IBA 01/2022 - 02/2020
2	LigandsIBA 12/2020 - 01/2015
2	ResveratrolIBA 04/2020 - 02/2020
2	Insulin (Novolin)FDA Link 12/2019 - 11/2004
1	Trace Elements (Biometals)IBA 03/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024
1	AtrazineIBA 01/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024
1	CurcuminIBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	Interleukin-18 (Interleukin 18)IBA 01/2024
1	NickelIBA 01/2024
1	dapagliflozinIBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2024
1	Serine (L-Serine)FDA Link 01/2024
1	Threonine (L-Threonine)FDA Link 01/2024
1	Diethylhexyl Phthalate (DEHP)IBA 01/2024
1	phthalic acid (phthalate)IBA 01/2024
1	Factor VIII (Coagulation Factor VIII)IBA 12/2023
1	VitronectinIBA 12/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023
1	LuciferasesIBA 12/2023
1	AlkaloidsIBA 12/2023
1	Bile Acids and Salts (Bile Acids)IBA 12/2023
1	BerberineIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 11/2023
1	Adenosine Triphosphate (ATP)IBA 07/2023
1	Sirtuin 1IBA 07/2023
1	Heavy MetalsIBA 07/2023
1	MycotoxinsIBA 06/2023
1	Aflatoxin B1 (Aflatoxin B)IBA 06/2023
1	ProteomeIBA 04/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Ribosomal DNA (rDNA)IBA 01/2023
1	EnzymesIBA 12/2022
1	LuteolinIBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	Phosphotransferases (Kinase)IBA 10/2022
1	Nonesterified Fatty Acids (NEFA)IBA 09/2022
1	Phosphatidylethanolamine Binding ProteinIBA 07/2022
1	CadmiumIBA 06/2022

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2004
3	Protein-Restricted Diet (Diet, Protein Restricted) 01/2021 - 05/2019
1	Secondary Prevention 09/2022